Paya Carlos V

Paya Carlos V is listed in filings as Director at Collegium Pharmaceutical, Inc.. This profile follows SEC Form 4 activity through May 18, 2026, including 8 public disclosures. Recent filings connect the profile to Collegium Pharmaceutical, Inc. (COLL) and Vaxcyte, Inc. (PCVX). The current snapshot covers public activity from Dec 10, 2024 to May 18, 2026. Reported amounts are shown as $529.7K to $525.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.